is trulicity tirzepatide SURPASS-CVOT Shows Mounjaro Surpasses in CV Outcomes Can weight-loss pens really deliver
Description
As such, there is currently no licensed treatment for people with obesity due to MC4R deficiency
Mounjaro (tirzepatide for type 2 diabetes or diabetes mellitus) is not for use in people with type 1 diabetes
You often need a maintenance dose for the best results
This combination is particularly relevant in cardiac tissue, where it contributes to the repolarization phase of the cardiac AP
doi: 10.1124/pr.108.000604
Some patients benefit from switching to compounded oral tirzepatide as an alternative delivery method, while others find that adjusting their injection technique or pre-medication routine resolves the issue entirely
